Aerovance

Aerovance

Verifiedclosed
Biotech company focused on developing and commercializing medicines for respiratory and allergic diseases.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$2—3m (Dealroom.co estimates Mar 2011.)
Berkeley California (HQ)
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor $0.0round
N/A$0.0round
investor investor $0.0round
investor investor investor investor investor investor investor $0.0round
investor investor $0.0round
$500kSeed
Total Funding000k

Recent News about Aerovance

Edit